Search Results - "Dasgupta, Kohinoor" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

by Dummer, Reinhard, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Kirkwood, John M, Chiarion Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Lesimple, Thierry, Plummer, Ruth, Dasgupta, Kohinoor, Gasal, Eduard, Tan, Monique, Long, Georgina V, Schadendorf, Dirk
Published in The New England journal of medicine (17.09.2020)

Get full text

Journal Article

PB1980: ASC4KIDS: A MULTICENTER, OPEN‐LABEL, PHASE 1B/2 STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

PB1980: ASC4KIDS: A MULTICENTER, OPEN‐LABEL, PHASE 1B/2 STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

by Hijiya, Nobuko, Kapoor, Shruti, Hoch, Matthias, Descamps, Laurence, Dasgupta, Kohinoor, Cardoso, Ana Paula Torres
Published in HemaSphere (08.08.2023)

Get full text

Journal Article

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma

Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected BRAF V600-Mutant Stage III Melanoma

by Hauschild, Axel, Dummer, Reinhard, Schadendorf, Dirk, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Lesimple, Thierry, Plummer, Ruth, Dasgupta, Kohinoor, Haas, Tomas, Shilkrut, Mark, Gasal, Eduard, Kefford, Richard, Kirkwood, John M, Long, Georgina V
Published in Journal of clinical oncology (10.12.2018)

Get full text

Journal Article

$Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study$

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

by Hargrave, Darren R, Bouffet, Eric, Tabori, Uri, Broniscer, Alberto, Cohen, Kenneth J, Hansford, Jordan R, Geoerger, Birgit, Hingorani, Pooja, Dunkel, Ira J, Russo, Mark W, Tseng, Lillian, Dasgupta, Kohinoor, Gasal, Eduard, Whitlock, James A, Kieran, Mark W
Published in Clinical cancer research (15.12.2019)

Get full text

Journal Article

ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in Chronic Phase

ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in Chronic Phase

by Hijiya, Nobuko, Kapoor, Shruti, Hoch, Matthias, Descamps, Laurence, Dasgupta, Kohinoor, Ramscar, Nicholas
Published in Blood (15.11.2022)

Get full text

Journal Article

Justification for Asciminib Dosing in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML-CP) with and without the T315I Mutation

Justification for Asciminib Dosing in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML-CP) with and without the T315I Mutation

by Combes, Francois Pierre, Li, Ying Fei, Sy, Sherwin K.B., Lorenzo, Sebastien, Dasgupta, Kohinoor, Kapoor, Shruti, Hoch, Matthias, Ho, Yu-Yun
Published in Blood (15.11.2022)

Get full text

Journal Article

Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation

Dose Justification for Asciminib in Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia with and Without the T315I Mutation

by Combes, Francois Pierre, Sy, Sherwin K. B., Li, Ying Fei, Lorenzo, Sebastien, Dasgupta, Kohinoor, Kapoor, Shruti, Hoch, Matthias, Ho, Yu-Yun
Published in Clinical pharmacokinetics (01.09.2024)

Get full text

Journal Article

Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia

Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia

by DeAngelo, Daniel J., Walker, Alison R., Schlenk, Richard F., Sierra, Jorge, Medeiros, Bruno C., Ocio, Enrique M., Röllig, Christoph, Strickland, Stephen A., Thol, Felicitas, Valera, Sue-zette, Dasgupta, Kohinoor, Berkowitz, Noah, Stuart, Robert K.
Published in Leukemia research (01.10.2019)

Get full text

Journal Article

Long-term benefit of adjuvant dabrafenib + trametinib (D+T) in patients (pts) with resected stage III BRAF V600–mutant melanoma: Five-year analysis of COMBI-AD

Long-term benefit of adjuvant dabrafenib + trametinib (D+T) in patients (pts) with resected stage III BRAF V600–mutant melanoma: Five-year analysis of COMBI-AD

by Hauschild, Axel, Dummer, Reinhard, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Kirkwood, John M., Chiarion Sileni, Vanna, Larkin, James M. G., Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew Mark, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Dasgupta, Kohinoor, Gasal, Eduard, Tan, Monique, Long, Georgina V., Schadendorf, Dirk
Published in Journal of clinical oncology (20.05.2020)

Get full text

Journal Article

A Randomized Trial of an Avatar-Hosted Multiple Behavior Change Intervention for Young Adult Smokers

by An, Lawrence C., Demers, Michele R. S., Kirch, Matthias A., Considine-Dunn, Shannon, Nair, Vijay, Dasgupta, Kohinoor, Narisetty, Naveen, Resnicow, Ken, Ahluwalia, Jasjit
Published in Journal of the National Cancer Institute. Monographs (01.12.2013)

Get full text

Journal Article

Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)–associated plexiform neurofibroma: A phase I/IIa study

Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)–associated plexiform neurofibroma: A phase I/IIa study

by McCowage, Geoffrey Brian, Mueller, Sabine, Pratilas, Christine A., Hargrave, Darren R, Moertel, Christopher L., Whitlock, James, Fox, Elizabeth, Hingorani, Pooja, Russo, Mark W., Dasgupta, Kohinoor, Tseng, Lillian, Mookerjee, Bijoyesh, Geoerger, Birgit
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN)

Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN)

by Geoerger, Birgit, Moertel, Christopher L., Whitlock, James, McCowage, Geoffrey Brian, Kieran, Mark W., Broniscer, Alberto, Hargrave, Darren R, Hingorani, Pooja, Kilburn, Lindsay Baker, Mueller, Sabine, Tseng, Lillian, Nebot, Noelia, Dasgupta, Kohinoor, Russo, Mark W., Fox, Elizabeth
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Discovering Functional Neuronal Connectivity from Serial Patterns in Spike Train Data

Discovering Functional Neuronal Connectivity from Serial Patterns in Spike Train Data

by Diekman, Casey, Dasgupta, Kohinoor, Nair, Vijay, Unnikrishnan, K. P.
Published in Neural computation (01.07.2014)

Get full text

Journal Article

LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB

LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB

by Bouffet, Eric, Kieran, Mark, Hargrave, Darren, Roberts, Stephen, Aerts, Isabelle, Broniscer, Alberto, Geoerger, Birgit, Dasgupta, Kohinoor, Tseng, Lillian, Russo, Mark, Mookerjee, Bijoyesh, Moertel, Christopher
Published in Neuro-oncology (Charlottesville, Va.) (22.06.2018)

Get full text

Journal Article

Reply to E. Hindié and K.R. Hess

Reply to E. Hindié and K.R. Hess

by Long, Georgina V, Dummer, Reinhard, Schadendorf, Dirk, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Schachter, Jacob, Lesimple, Thierry, Plummer, Ruth, Dasgupta, Kohinoor, Haas, Tomas, Shilkrut, Mark, Gasal, Eduard, Kefford, Richard, Kirkwood, John M, Hauschild, Axel
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF V600E or BRAF V600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF V600E or BRAF V600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

by Schadendorf, Dirk, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Lesimple, Thierry, Plummer, Ruth, Schachter, Jacob, Dasgupta, Kohinoor, Manson, Stephanie, Koruth, Roy, Mookerjee, Bijoyesh, Kefford, Richard, Dummer, Reinhard, Kirkwood, John M, Long, Georgina V
Published in The lancet oncology (01.05.2019)

Get full text

Journal Article

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

by Schadendorf, Dirk, Hauschild, Axel, Santinami, Mario, Atkinson, Victoria, Mandalà, Mario, Chiarion-Sileni, Vanna, Larkin, James, Nyakas, Marta, Dutriaux, Caroline, Haydon, Andrew, Robert, Caroline, Mortier, Laurent, Lesimple, Thierry, Plummer, Ruth, Schachter, Jacob, Dasgupta, Kohinoor, Manson, Stephanie, Koruth, Roy, Mookerjee, Bijoyesh, Kefford, Richard, Dummer, Reinhard, Kirkwood, John M, Long, Georgina V
Published in The lancet oncology (01.05.2019)

Get full text

Journal Article

Dabrafenib in pediatric patients with BRAF V600–positive high-grade glioma (HGG)

Dabrafenib in pediatric patients with BRAF V600–positive high-grade glioma (HGG)

by Hargrave, Darren R, Moreno, Lucas, Broniscer, Alberto, Bouffet, Eric, Aerts, Isabelle, Andre, Nicolas, Shen, Wei-Ping Violet, Bertozzi-Salamon, Anne-Isabelle, Cohen, Kenneth J., Dunkel, Ira J., Kieran, Mark W., Lissat, Andrej, Russo, Mark W., Dasgupta, Kohinoor, Tseng, Lillian, Mookerjee, Bijoyesh, Geoerger, Birgit
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

$Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed refractory low-grade glioma$

Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed refractory low-grade glioma

by Kieran, Mark W., Bouffet, Eric, Broniscer, Alberto, Cohen, Kenneth J., Geoerger, Birgit, Hansford, Jordan R., Hingorani, Pooja, Aerts, Isabelle, Andre, Nicolas, Bertozzi-Salamon, Anne-Isabelle, Dunkel, Ira J., Hummel, Trent Ryan, Leary, Sarah, Moreno, Lucas, Russo, Mark W., Tseng, Lillian, Dasgupta, Kohinoor, Nebot, Noelia, Whitlock, James, Hargrave, Darren R
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Explaining state-to-state differences in seat belt use: A multivariate analysis of cultural variables

Explaining state-to-state differences in seat belt use: A multivariate analysis of cultural variables

by Molnar, Lisa J., Eby, David W., Dasgupta, Kohinoor, Yang, Yang, Nair, Vijayan N., Pollock, Stephen M.
Published in Accident analysis and prevention (01.07.2012)

Get full text

Journal Article